Cliff Asness’s Biohaven BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$61.8M Buy
4,150,616
+2,175,100
+110% +$23.4M 0.02% 760
2026
Q1
$16.7M Buy
1,975,516
+515,408
+35% +$5.64M 0.01% 1102
2025
Q4
$16.5M Buy
1,460,108
+1,246,841
+585% +$15.4M 0.01% 1008
2025
Q3
$3.2M Buy
213,267
+135,419
+174% +$1.97M ﹤0.01% 1705
2025
Q2
$1.1M Sell
77,848
-37,001
-32% -$659K ﹤0.01% 2150
2025
Q1
$2.76M Buy
114,849
+37,981
+49% +$1.34M ﹤0.01% 1433
2024
Q4
$2.87M Buy
76,868
+26,018
+51% +$1.21M ﹤0.01% 1333
2024
Q3
$2.54M Sell
50,850
-3,511
-6% -$137K ﹤0.01% 1377
2024
Q2
$1.89M Buy
54,361
+38,101
+234% +$1.51M ﹤0.01% 1470
2024
Q1
$889K Buy
16,260
+6,026
+59% +$298K ﹤0.01% 1747
2023
Q4
$438K Buy
+10,234
New +$318K ﹤0.01% 1940

Other funds holding BHVN

Cliff Asness's BHVN Position: Q2 2026 in Review

Cliff Asness increased its Biohaven (BHVN) stake by 110% in Q2 2026, buying an estimated $23.4M and bringing the position to 4,150,616 shares worth $61.8M. The position accounts for 0.02% of the portfolio, ranked #760.

Cliff Asness first reported a position in BHVN in Q4 2023 and has held it in 11 quarters since. 292 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Cliff Asness held 4,150,616 shares of Biohaven worth $61.8M as of Q2 2026.
  • Cliff Asness bought 2,175,100 Biohaven shares in Q2 2026, an estimated $23.4M.
  • Biohaven made up 0.02% of Cliff Asness's portfolio in Q2 2026, its #760 holding.
  • Cliff Asness first reported a position in Biohaven in Q4 2023 and has held it in 11 quarters since.
  • 292 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.